MYP_104496
peptide 13 (derived from OH-CM6)
Anticancer
▸
Cytotoxic anticancer activity
▸
Cytotoxic
Antimicrobial
Antimicrobial
▸
Antibacterial
Antimicrobial
▸
Antibacterial
▸
Anti-Gram-negative
Antimicrobial
▸
Antibacterial
▸
Anti-Gram-positive
Antimicrobial
▸
Antifungal
Toxicity / Safety
▸
Blood cell toxicity
▸
Hemolysis
▸
Hemolytic
Toxicity / Safety
▸
Cytotoxicity
▸
Cytotoxic
Venom / Toxin
▸
General toxin
▸
Cytotoxic
Standard
20 amino acids
C120H200N30O21
Standard
KFFKKLKKAVKKGFKKFAKV
2399.06 Da
10.95
9.75
9.53
0.4875
-0.62
0.85
-0.27
-23.95
58.50
0.2000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
876.42
-2.10
31.0
31.0
91.0
171.0
4.0
19.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0087472
VERIFIED: YES
Provenance & Taxonomy
Synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial
Antibacterial
Anti-Gram-positive
Anti-Gram-negative
Candida albicans clinical strain
200 μg/mL
MIC
RECORD: Rec_0093613
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
OH-CM6
32630
Structure & Mods
lysine-tethered side-chain cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
Amidation
The Ⓚ (position: 12 and 19) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. Ⓚ (12) and Ⓚ (19) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction
Bio-Activity Profile
Antimicrobial
Antibacterial
Staphylococcus aureus
4 μg/mL
MIC99.9
RECORD: Rec_0104632
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
OH-CM6
32630
Structure & Mods
lysine-tethered side-chain cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
Amidation
The Ⓚ (position: 5 and 12) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. Ⓚ (5) and Ⓚ (12) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction
Bio-Activity Profile
Antimicrobial
Antibacterial
Pseudomonas aeruginosa
8 μg/mL
MIC99.9
RECORD: Rec_0106823
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
OH-CM6
32630
Structure & Mods
lysine-tethered side-chain cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
Amidation
The Ⓚ (position: 15 and 19) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. Ⓚ (15) and Ⓚ (19) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction
Bio-Activity Profile
Antimicrobial
Antibacterial
Staphylococcus aureus
8 μg/mL
MIC99.9
RECORD: Rec_0112489
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
OH-CM6
32630
Structure & Mods
lysine-tethered side-chain cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
Amidation
The Ⓚ (position: 8 and 15) in sequence indicates Nε-o-Ns-Nα-Fmoc-lysine before stapling. Ⓚ (8) and Ⓚ (15) are cross-linked by a (E)-but-2-enyl spacer employing the N-alkylation reaction
Bio-Activity Profile
Antimicrobial
Antibacterial
Pseudomonas aeruginosa
16 μg/mL
MIC99.9
Showing 5 records on this page · Page 6 of 31